Stock Market Rally: Revvity, Avantor, Azenta, Bio-Techne, Amneal Shares Surge Amid Fed Interest Rate Cut Hopes
ByAinvest
Tuesday, Aug 12, 2025 2:26 pm ET1min read
AMRX--
The prevailing view is that easing inflation gives the central bank room to lower interest rates, which typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds. The Federal Reserve is expected to leave the Fed funds rate unchanged in a range of 4.25% to 4.50% at its upcoming meeting, but investors are closely monitoring for any hints of a potential rate cut in the future [2].
Revvity, which launched innovative reagent technology to accelerate the development of next-generation targeted therapeutics, saw its stock price surge. The company's Q2 earnings call highlighted strong software growth and strategic shareholder initiatives [3]. Avantor, a provider of scientific and technical products, also experienced significant gains, driven by strong demand for its products in the healthcare and life sciences sectors.
Azenta, Bio-Techne, and Amneal also benefited from the market rally, with their stock prices increasing due to the overall positive sentiment in the market. The market's focus has shifted from recent U.S. trade deals to economic data, a new round of corporate earnings reports, and the start of the Federal Reserve’s two-day policy meeting [2].
The S&P 500 E-Mini futures (ESU25) are trending up +0.24% this morning, extending yesterday’s gains, while investors await the outcome of the Federal Reserve’s policy meeting. The central bank is widely expected to leave the Fed funds rate unchanged, but investors will closely monitor Chair Jerome Powell’s post-policy meeting press conference for clues on a potential September rate cut [2].
The market's optimism is further fueled by the recent U.S.-EU trade deal, which has been seen as a positive development for global trade. The deal has faced criticism from numerous voices across the Eurozone, but the EU and U.S. will seek to finalize a non-legally binding joint statement by August 1st [2].
References:
[1] https://finance.yahoo.com/quote/RVTY/news/
[2] https://www.inkl.com/news/s-p-futures-gain-with-focus-on-u-s-jolts-report-and-corporate-earnings-fomc-meeting-on-tap
[3] https://www.gurufocus.com/stock/RVTY
AVTR--
AZTA--
BIO--
RVTY--
Several stocks, including Revvity, Avantor, Azenta, Bio-Techne, and Amneal, surged after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The Consumer Price Index report showed inflation rose by 0.2% in July and 2.7% over the last year. This led to a market rally, with the S&P 500, Dow, and Nasdaq all climbing. The prevailing view is that easing inflation gives the central bank room to lower interest rates, which typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds.
Several stocks, including Revvity (RVTY), Avantor (AVTR), Azenta (AZTA), Bio-Techne (BIO), and Amneal (AMNL), surged after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The Consumer Price Index (CPI) report showed inflation rose by 0.2% in July and 2.7% over the last year [1]. This led to a market rally, with the S&P 500, Dow, and Nasdaq all climbing.The prevailing view is that easing inflation gives the central bank room to lower interest rates, which typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds. The Federal Reserve is expected to leave the Fed funds rate unchanged in a range of 4.25% to 4.50% at its upcoming meeting, but investors are closely monitoring for any hints of a potential rate cut in the future [2].
Revvity, which launched innovative reagent technology to accelerate the development of next-generation targeted therapeutics, saw its stock price surge. The company's Q2 earnings call highlighted strong software growth and strategic shareholder initiatives [3]. Avantor, a provider of scientific and technical products, also experienced significant gains, driven by strong demand for its products in the healthcare and life sciences sectors.
Azenta, Bio-Techne, and Amneal also benefited from the market rally, with their stock prices increasing due to the overall positive sentiment in the market. The market's focus has shifted from recent U.S. trade deals to economic data, a new round of corporate earnings reports, and the start of the Federal Reserve’s two-day policy meeting [2].
The S&P 500 E-Mini futures (ESU25) are trending up +0.24% this morning, extending yesterday’s gains, while investors await the outcome of the Federal Reserve’s policy meeting. The central bank is widely expected to leave the Fed funds rate unchanged, but investors will closely monitor Chair Jerome Powell’s post-policy meeting press conference for clues on a potential September rate cut [2].
The market's optimism is further fueled by the recent U.S.-EU trade deal, which has been seen as a positive development for global trade. The deal has faced criticism from numerous voices across the Eurozone, but the EU and U.S. will seek to finalize a non-legally binding joint statement by August 1st [2].
References:
[1] https://finance.yahoo.com/quote/RVTY/news/
[2] https://www.inkl.com/news/s-p-futures-gain-with-focus-on-u-s-jolts-report-and-corporate-earnings-fomc-meeting-on-tap
[3] https://www.gurufocus.com/stock/RVTY

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet